VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
102 hedge funds and large institutions have $1.07B invested in Verona Pharma in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
64% less call options, than puts
Call options by funds: $1.12M | Put options by funds: $3.1M
Holders
102
Holding in Top 10
9
Calls
$1.12M
Puts
$3.1M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$13.9M | |
| 3 | +$13.4M | |
| 4 |
Millennium Management
New York
|
+$6.53M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$4.63M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$8.07M | |
| 3 | -$6.36M | |
| 4 |
Two Sigma Investments
New York
|
-$5.44M |
| 5 |
Two Sigma Advisers
New York
|
-$3.92M |